| Renflexis |
761054 |
001 |
351(k) Biosimilar |
infliximab-abda |
For Injection |
Intravenous |
100MG |
Single-Dose Vial |
2017/04/21
|
Samsung Bioepis Co., Ltd. |
Rx |
Licensed |
infliximab |
Remicade |
| Afstyla |
125591 |
006 |
351(a) |
Antihemophilic Factor (Recombinant), Single Chain |
For Injection |
Intravenous |
2500IU |
Single-Dose Vial |
2017/03/31
|
CSL Behring Lengnau AG |
Rx |
Licensed |
|
N/A |
| Afstyla |
125591 |
007 |
351(a) |
Antihemophilic Factor (Recombinant), Single Chain |
For Injection |
Intravenous |
1500IU |
Single-Dose Vial |
2017/03/31
|
CSL Behring Lengnau AG |
Rx |
Licensed |
|
N/A |
| Orencia |
125118 |
004 |
351(a) |
abatacept |
Injection |
Subcutaneous |
50MG/0.4ML |
Pre-Filled Syringe |
2017/03/30
|
Bristol-Myers Squibb Company |
Rx |
Licensed |
N/A |
N/A |
| Orencia |
125118 |
005 |
351(a) |
abatacept |
Injection |
Subcutaneous |
87.5MG/0.7ML |
Pre-Filled Syringe |
2017/03/30
|
Bristol-Myers Squibb Company |
Rx |
Licensed |
N/A |
N/A |
| Ocrevus |
761053 |
001 |
351(a) |
ocrelizumab |
Injection |
Intravenous |
300MG/10ML (30MG/ML) |
Single-Dose Vial |
2017/03/28
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Dupixent |
761055 |
001 |
351(a) |
dupilumab |
Injection |
Subcutaneous |
300MG/2ML |
Pre-Filled Syringe |
2017/03/28
|
Regeneron Pharmaceuticals, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Dupixent |
761055 |
002 |
351(a) |
dupilumab |
Injection |
Subcutaneous |
300MG/2ML |
Pre-Filled Syringe |
2017/03/28
|
Regeneron Pharmaceuticals, Inc. |
Disc |
Licensed |
N/A |
N/A |
| Bavencio |
761049 |
001 |
351(a) |
avelumab |
Injection |
Intravenous |
200MG/10ML (20MG/ML) |
Single-Dose Vial |
2017/03/23
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Adynovate |
125566 |
007 |
351(a) |
Antihemophilic Factor (Recombinant), PEGylated |
For Injection |
Intravenous |
3000IU |
Single-Dose Vial |
2017/03/13
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Flucelvax, Flucelvax Quadrivalent |
125408 |
003 |
351(a) |
Influenza Vaccine |
Injection |
Intramuscular |
60UG/.5ML |
Multi-Dose Vial |
2017/03/03
|
Seqirus Inc. |
Disc |
Licensed |
N/A |
N/A |
| Rubber Panel T.R.U.E. Test |
125579 |
001 |
351(a) |
Rubber Panel Thin-Layer Rapid Use Epicutaneous Patch Test |
Patch |
Topical |
PATCH TEST 5 ALLERGEN AND ALLERGEN MIX PATCHES AND A NEGATIVE CONTROL. |
Blister Pack |
2017/03/03
|
SmartPractice Denmark ApS |
Rx |
Licensed |
|
N/A |
| Odactra |
125592 |
001 |
351(a) |
House Dust Mites (Dermatophagoides farinae and Dermatophagoides pteronyssinus) Allergen Extract |
Tablet |
Sublingual |
12 SQ-HDM/ML |
Blister Pack |
2017/03/01
|
ALK - Abello A/S |
Rx |
Licensed |
|
N/A |
| Jetrea |
125422 |
001 |
351(a) |
ocriplasmin |
Injection |
Intravitreal |
0.375MG/0.3ML (1.25MG/ML) |
Single-Dose Vial |
2017/02/22
|
ThromboGenics Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Siliq |
761032 |
001 |
351(a) |
brodalumab |
Injection |
Subcutaneous |
210MG/1.5ML |
Pre-Filled Syringe |
2017/02/15
|
Bausch Health Ireland, Limited |
Rx |
Licensed |
N/A |
N/A |
| Herceptin |
103792 |
002 |
351(a) |
trastuzumab |
For Injection |
Intravenous |
150MG |
Single-Dose Vial |
2017/02/10
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Gammaplex |
125329 |
005 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
5G/50ML |
Single-Dose Vial |
2017/02/06
|
Bio Products Laboratory Limited |
Rx |
Licensed |
|
N/A |
| Gammaplex |
125329 |
006 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
10G/100ML |
Single-Dose Vial |
2017/02/06
|
Bio Products Laboratory Limited |
Rx |
Licensed |
|
N/A |
| Gammaplex |
125329 |
007 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
20G/200ML |
Single-Dose Vial |
2017/02/06
|
Bio Products Laboratory Limited |
Rx |
Licensed |
|
N/A |
| Eloctate |
125487 |
008 |
351(a) |
Antihemophilic Factor (Recombinant), Fc Fusion protein |
For Injection |
Intravenous |
5000IU |
Single-Dose Vial |
2017/01/27
|
Bioverativ Therapeutics, Inc. |
Rx |
Licensed |
|
N/A |